DrugPatentWatch Database Preview
Bionpharma Inc Company Profile
What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?
There are three US patents protecting BIONPHARMA INC drugs.
There are nineteen patent family members on BIONPHARMA INC drugs in seventeen countries and twenty-one supplementary protection certificates in eleven countries.
Summary for Bionpharma Inc
| International Patents: | 19 |
| US Patents: | 3 |
| Tradenames: | 26 |
| Ingredients: | 22 |
| NDAs: | 25 |
| Drug Master File Entries: | 1 |
| Patent Litigation for Bionpharma Inc: | See patent lawsuits for Bionpharma Inc |
Drugs and US Patents for Bionpharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma Inc | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | OTC | Yes | Yes | 6,251,426 | ➤ Sign Up | ➤ Sign Up | ||||
| Bionpharma Inc | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 021920-001 | Feb 17, 2006 | OTC | Yes | Yes | 9,693,978 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Bionpharma Inc | CALCITRIOL | calcitriol | CAPSULE;ORAL | 091174-001 | May 24, 2013 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Bionpharma Inc | TETRABENAZINE | tetrabenazine | TABLET;ORAL | 208826-002 | Dec 18, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Bionpharma Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1863458 | ➤ Sign Up |
| European Patent Office | 3061447 | ➤ Sign Up |
| European Patent Office | 1207872 | ➤ Sign Up |
| Germany | 60034044 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Bionpharma Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2012000051 | Germany | ➤ Sign Up | PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105 |
| 11/016 | Ireland | ➤ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105 |
| 00481 | Netherlands | ➤ Sign Up | PRODUCT NAME: NAPROXEN EN ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17901/0263-001 20101105 |
| 01C/045 | Belgium | ➤ Sign Up | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
